Honokiol inhibited tumor cell proliferation (half maximal effective concentration: 3.3 – 7.4 μM), induced apoptosis, and suppressed key EGFR downstream signaling pathways, including MAPK, AKT, and STAT3. The gene discussed is EGFR; the disease is neoplasm.